Skip Navigation



Journal of the National Cancer Institute Advance Access published online on September 11, 2007
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djm109
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/18/1416    most recent
djm109v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ferretti, G.
Right arrow Articles by Cognetti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferretti, G.
Right arrow Articles by Cognetti, F.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Re: Polychemotherapy for Early Breast Cancer: Results From the International Adjuvant Breast Cancer Chemotherapy Randomized Trial

Gianluigi Ferretti, Alessandra Felici, Paolo Carlini, Francesco Cognetti

Affiliations of authors: Division of Medical Oncology A, Regina Elena Cancer Institute, Rome, Italy

Correspondence to: Gianluigi Ferretti, MD, PhD, Division of Medical Oncology A, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy (e-mail: gia.fer@flashnet.it).

The first 10% of the full text of this article appears below.

According to the Adjuvant Breast Cancer Trials Collaborative Group (ABCTCG) trial (1), improvements (non–statistically significant in relapse-free survival but statistically significant in overall survival) with chemotherapy combined with tamoxifen were seen especially among women younger than age 50 years and in particular premenopausal women who did not receive . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Polychemotherapy for Early Breast Cancer: Results From the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
The Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst 2007 99: 506-515. [Abstract] [Full Text] [PDF]